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A B S T R A C T
Oxytocin has been shown to stimulate social approach behaviors, although effects may depend on contextual and
individual difference factors. Here, we examined intranasal oxytocin effects on interpersonal distance using an
immersive Virtual Reality paradigm, taking into account early caregiving experiences and interpersonal context
as potential moderators. Participants were 180 women who received 24 IU oxytocin or a placebo and had
reported how often their mother used love withdrawal as a disciplinary strategy, involving withholding love and
affection after a failure or misbehavior. We used a virtual stop-distance paradigm, instructing participants to
approach a virtual person or to stop an approaching virtual person at a preferred distance (passive approach). In
order to examine the role of interpersonal context in shaping oxytocin effects, facial expressions and bodily
gestures of the virtual person were manipulated. The person showed a dynamical expression of sadness, hap-
piness, anger, fear, disgust, or no emotional expression in six different emotion conditions. We found that
oxytocin reduced interpersonal distance across the different emotion conditions, but only in individuals with
lower levels of love withdrawal. In addition, oxytocin reduced anxiety levels during passive approach, in par-
ticular in the disgust condition, but only in individuals with lower levels of maternal disciplinary love with-
drawal. Individuals with more love withdrawal experienced more anxiety while being approached by a virtual
person displaying disgust or fear, but benefitted less from anxiety-reducing oxytocin effects. These results are
consistent with previous research showing a dysregulated oxytocinergic system after childhood adversity and
indicate that oxytocin may be less effective for individuals who are most in need of an intervention because of a
problematic family background.
1. Introduction
Interpersonal distance is the space we choose to maintain with other
people. It is considered a form of nonverbal communication that plays
an important role in social interactions and varies depending on in-
dividual preferences (Iachini et al., 2016), contexts (Scheele et al.,
2012), and the familiarity of the person with whom the space is shared.
For example, we choose to maintain a greater distance to strangers than
close friends (Güroğlu et al., 2008), suggesting that interpersonal dis-
tance is an indicator of affiliation and emotional closeness. Inter-
personal distance has also been interpreted as a tendency to either
approach or avoid social stimuli (Cohen and Shamay-Tsoory, 2018),
related to affective needs and boundaries (Bekker et al., 2016). It is
often examined with stop-distance paradigms, in which the participant
is either asked to stop an approaching person at a preferred distance or
is asked to control the size of their interpersonal space by actively ap-
proaching the other person and choosing themselves when to stop.
Previous studies have explored neurobiological mechanisms un-
derlying individual differences in interpersonal distance and point to a
role of the neuropeptide oxytocin in regulating social approach (Cohen
et al., 2017). Oxytocin is involved in a range of social behaviors and has
been shown to stimulate trust (Van IJzendoorn and Bakermans-
Kranenburg, 2012), in-group altruism (De Dreu et al., 2010), empathy
(Shamay-Tsoory et al., 2013), and emotion recognition (Shahrestani
et al., 2013). One hypothesis that has been proposed to explain these
general social effects is the social approach/withdrawal hypothesis of
oxytocin, which states that oxytocin increases social approach beha-
viors and decreases withdrawal behaviors (Harari-Dahan and Bernstein,
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2014, 2017; Piva and Chang, 2018). However, with respect to inter-
personal distance, conflicting results have been found, with oxytocin
inducing either closeness or separation. For example, Scheele et al.
(2012) showed that intranasal administration of oxytocin resulted in a
greater distance between men in a monogamous relationship and an
attractive woman. Similarly, Cohen et al.(2017) showed that intranasal
oxytocin increased interpersonal distance in a paradigm with ap-
proaching protagonists, in particular to strangers. In contrast, oxytocin
increased social approach behaviors in a paradigm in which partici-
pants actively exerted control over their space and were instructed to
actively approach the other person (Cohen and Shamay-Tsoory, 2018).
One explanation that has been proposed for these seemingly con-
trasting findings is that stop-distance paradigms that contain ap-
proaching figures may provoke threat from personal space intrusion
(Cohen et al., 2018). In the context of threat, oxytocin may induce a
tendency to separation and increase social space, whereas it may sti-
mulate a tendency to closeness in the absence of threat. Indeed, con-
textual factors have been shown to moderate and shape the direction of
the effects of oxytocin on social behavior (Bartz et al., 2011). More
specifically, oxytocin stimulates trust and altruistic behaviors towards
in-group members or in safe social situations, but at the same time
increases antisocial behaviors towards threatening out-group members
and in hostile contexts (De Dreu, 2012). These paradoxical effects may
be explained by another prominent hypothesis for oxytocin effects on
social behavior: The social salience hypothesis, which states that oxy-
tocin increases sensitivity to social cues of safety and threat (Shamay-
Tsoory and Abu-Akel, 2016). This general effect of increased salience of
contextual cues has been proposed to underlie the paradoxical effects of
oxytocin, with increased approach and affiliative responses in safe si-
tuations but more avoidant or defensive responses in the presence of
threat.
In addition to contextual factors, individual difference factors have
also been shown to moderate the effects of oxytocin (Bartz et al., 2011).
More specifically, studies point to a moderating role of early childhood
experiences on the prosocial effects of intranasal oxytocin and indicate
that individuals with negative childhood experiences show reduced
sensitivity to oxytocin (Bakermans-Kranenburg and Van IJzendoorn,
2013). For example, oxytocin has stress-reducing effects, as reflected by
cortisol decreases after social stress, but these effects are impeded in
individuals with a history of early parental separation (Meinlschmidt
and Heim, 2007). Similarly, in several previous studies, we showed that
oxytocin effects on social behavior are absent in individuals with ex-
periences of maternal use of love withdrawal (Riem et al., 2013a,), a
disciplinary strategy that involves withholding love and affection when
a child misbehaves. Parental use of love withdrawal has been associated
with negative child outcomes, including fear of failure (Huffmeijer
et al., 2013), and it is considered emotional maltreatment when it is
used excessively (Euser et al., 2010).
In the current study, we examined intranasal oxytocin effects on
interpersonal distance, taking into account both contextual and in-
dividual difference moderators. We used a newly developed immersive
Virtual Reality (VR) paradigm (Steenbakkers et al., 2019), in which
female participants were instructed to either approach a virtual person
with different emotional expressions or to stop an approaching virtual
person at their preferred distance. In order to examine the role of in-
terpersonal context in shaping oxytocin effects, we manipulated the
facial expression of the virtual person and we devised the VR paradigm
so that the virtual person showed a dynamical bodily and facial ex-
pression of sadness, happiness, anger, fear, disgust, or no emotional
expression in different emotion conditions. Two contrasting predictions
can be made regarding how oxytocin will affect distance in these so-
cially varying contexts. 1).According to the approach/withdrawal hy-
pothesis, oxytocin would stimulate approach behaviors in positively-
valenced interactions and would reduce withdrawal behaviors in ne-
gatively-valenced interactions, possibly through anxiety reduction
(Piva and Chang, 2018). This would result in reduced interpersonal
distance in both negatively-valenced and positively-valenced interac-
tions. 2). In contrast, according to the social salience hypothesis, oxy-
tocin would enhance the salience of social cues, and, as a result, would
lead to opposing effects during interactions signalling threat versus
safety. Thus, oxytocin would stimulate sensitivity to the emotional
expressions, would enhance prosocial approach behaviors towards a
person displaying sad or happy facial expressions (signalling safety and
absence of threat), but would increase distance from a person dis-
playing angry, fearful, or disgusted facial expressions (signalling po-
tential threat or rejection). In addition, we examined the role of ma-
ternal use of love withdrawal in shaping oxytocin effects and regulating
interpersonal distance. Consistent with previous studies, we expected
that oxytocin effects would be less pronounced in individuals with more
experiences of love withdrawal.
2. Materials and methods
2.1. Participants
The sample consisted of 180 female undergraduate students from
Tilburg University. The ages ranged from 18 to 27 years old (M =
20.12, SD=1.78). The majority of participants were born in the
Netherlands (48.9%), Germany (28.9%), or another European country
(20.6%) and did not have prior experience with virtual reality (86.7%).
Of all participants 56.7% used hormonal contraceptives. Exclusion
criteria involved drug or alcohol abuse, nasal problems, use of pre-
scribed medication (except contraception), psychiatric and neurological
disorders, cardiovascular diseases, and a high blood pressure. Further,
participants who were pregnant, breastfed or had children were ex-
cluded from this study. Participants were randomly assigned to the
oxytocin or the placebo condition (N=90 oxytocin, N=90 placebo).
Sample size was based on an a priori power analysis using G*Power 3.1
for repeated measures (within-between interactions), which showed
that a sample size of 166 is sufficient to detect small effects (f= .10,
α= .05, power .95, 6 measurements, 2 groups). Oversampling was
done in order to be able to test moderation effects of love withdrawal.
Participants received a monetary reward or study credits for partici-
pation. Permission for this study was obtained from the Medical Ethics
Committee Brabant (NL60593.028.17) and all participants gave in-
formed consent. The study was registered in the Dutch Trial Register
(NTR6513).
2.2. Procedure
Participants were asked to complete questionnaires on childhood
experiences approximately one week before a lab session. They were
invited for the lab session, preferably in the luteal phase of their
menstrual cycle in order to control for influences of menstrual cycle.
During the luteal phase, plasma oxytocin levels are lower (Salonia et al.,
2005) and more responsive to stimulation such as by nipple stimulation
(Leake et al., 1984). Women were asked about the date of their last
menstruation and this information was used to schedule the lab session.
Menstrual phase and hormonal contraceptives were balanced across the
placebo and oxytocin group: 12 participants in the oxytocin and 11
participants in the placebo group were in the follicular phase, whereas
79 participants in the oxytocin group and 78 participants in the placebo
group were in the luteal phase. In the placebo group, 57 participants
used hormonal contraceptives, and in the oxytocin group, 45 partici-
pants used hormonal contraceptives. They were instructed to abstain
from alcohol during the 24 h before the start of study, and from caffeine
and smoking on the data collection day. At the start of the lab session,
participants took 6 puffs of nasal spray containing oxytocin (24 IU total)
or 6 puffs of a placebo spray under supervision of the experimenter.
Drug administration was double-blind. Participants started with prac-
tice trials of the virtual interpersonal distance paradigm approximately
15min after nasal spray administration. The actual paradigm was
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administered approximately 20min after administration. Previous stu-
dies have shown intranasal oxytocin effects after similar waiting time
(MacDonald et al., 2011).
2.3. Virtual interpersonal distance paradigm
We used a newly developed interpersonal distance Virtual Reality
(VR) paradigm, developed in collaboration with the DAF Technology
Lab, Tilburg University (Steenbakkers et al., 2019), based on the Dis-
tance-Closeness paradigm described by Bekker et al. (2016). This VR
paradigm permits participants to control the interpersonal distance
between a virtual person (avatar) of the same sex and themselves, using
a control-box (held-hand single button operated with a thumb) in a
three-dimensional computer-generated environment. It enables accu-
rate measurement of approach behaviors and optimal control over ex-
perimental conditions in an immersive dynamically adaptable real-life
setting.
2.3.1. Adaptations to the interpersonal distance paradigm and used
equipment
The paradigm was adapted for the current study and administered
in the Behavioral Physiology lab (GO-LAB), Tilburg University, using
the Oculus Rift DK2 VR-setup. This setup consists of VR-Glasses and
sensors monitoring head orientation. The virtual environment was a
square room with a same sex avatar (female) standing in front of the
participant (see Fig. 1). The participant and the avatar were positioned
on a diagonal line in the virtual room. The virtual setting was created
and adapted in Unity. The avatars were purchased online through the
unity asset store (https:www.assetstore.unity3d.com/en#!/content/
1760). Facial expressions of the avatars were also adapted for the
study using Unity.
The Spielberger Trait State Anxiety Inventory (STAI) short form (6
items, Marteau and Bekker, 1992; Cronbach's alpha= .71, M=1.78,
SD= .48, range 1–5) was embedded within the virtual task for the
measurement of state anxiety. The questions were presented on a vir-
tual wall in the virtual setting. The participants were instructed to select
an answer on a virtual wall with a hovering pointer controlled by head
movement measured by the Oculus Rift DK2 setup.
2.3.2. Virtual procedure
Before the start of the task, participants were familiarized with an
immersive VR with several practice trials to rule out any effects on
anxiety levels due to wow-effects due to inexperience with immersive
VR. During the practice trials participants were asked to indicate a
preferred position of a neutral “pill”-shaped object. The practice trials
were followed by a baseline measurement of state anxiety using the
Dutch or English version of the STAI.
The Virtual Interpersonal Distance paradigm started after the
baseline anxiety assessment. At the start of each trial, the distance be-
tween the avatar and the participant was an equivalent of 3.5 virtual
meters. The task consisted of two blocks. In the first block, the parti-
cipant is approached by an avatar and is asked to stop the avatar at a
preferred distance by using the control box. Participants were in-
structed to stop the walking avatar when they started feeling slightly
uncomfortable. In the second block, the participant was instructed to
walk towards the avatar in the virtual environment by using the control
box and to stop at her preferred distance.
In adaptation to the Virtual Interpersonal Distance Paradigm, the
current study used different facial expressions and bodily gestures for
the avatar other than neutral. In both blocks, the emotional facial ex-
pression and the bodily gestures of the avatar were neutral at the start
of each trial, but changed into angry, sad, fearful, disgusted, or happy in
different emotion conditions, or remained neutral in a control condition
(see supplemental material for a video fragment of the task). The avatar
started expressing the emotions and after a few seconds, she walked
towards the participant while dynamically expressing an emotion (or
without expressing emotion in the neutral condition). Similarly, the
avatar kept dynamically displaying the emotion during the entire trial
in the condition in which the participant walked towards the person.
After each trial, participants rated how angry, sad, happy, disgusted, or
anxious the avatar appeared in each condition. This was rated on a five-
point Likert scale from 1 (“not at all”) to 5 (“very much”). In addition,
state anxiety was measured after each trial. The maximum amount of
time of each trial was 10 s. The order of emotion conditions was random
and each emotion condition was administered once. A pilot study with
13 undergraduate students showed that the emotions of the avatar were
correctly recognized (see Supplemental Material).
2.4. Maternal disciplinary use of love withdrawal
The 11-item questionnaire on maternal use of love withdrawal
contained seven items of the Withdrawal of Relations subscale of the
Children's Report of Parental Behavior Inventory (CRPBI; (Beyers and
Goossens, 2003)) and four items from the Parental Discipline
Fig. 1. Virtual Interpersonal Distance Paradigm in the happy condition (A, start of the trial) and fear condition (B, start of the trial), the sad (C), angry (D), and
disgust condition (E).
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Questionnaire (Hoffman and Saltzstein, 1967), and has been used in
previous research (Huffmeijer et al., 2013, 2014; Riem et al., 2014,
2017). Because it is in particular the use of maternal love withdrawal
that has been related to low emotional well-being in adolescence and
adulthood (Elliot and Thrash, 2004; Renk et al., 2006), we focused on
maternal behavior only. The questionnaire was completed online
during the first phase of the study. Participants rated how well each of
the 11 statements described their mother (e.g., “My mother is a person
who, when I disappoint her, tells me how sad I make her”) on a 5-point
scale ranging from 1 (not at all) to 5 (very well). Reliability in our
sample was .84. Mean total score was 2.30 (SD=0.82, range of
1–4.36). The scores did not differ for participants in the oxytocin or
placebo condition, t(178) = -0.64, p= .52. Scores were normally
distributed.
2.5. Data analyses
Anxiety scores and distances were inspected for outliers. Outliers
(N=1 for anxiety in the happy virtual person participant moves con-
dition, N=1 happy virtual person moves condition) were replaced
with the maximum value. Correlations were calculated between love
withdrawal and the ratings of the emotions corresponding to the facial
expression of the avatar (i.e. sadness rating of the sad female avatar). As
previous research has shown that oxytocin affects perception of emo-
tions (Shahrestani, Kemp, & Guastella, 2013), analyses of variance
(ANOVA) were performed to test whether oxytocin affected the emo-
tion ratings of the facial expressions. The emotion ratings corre-
sponding to the facial expression of the virtual person (averaged for the
‘approaching participant’ and ‘approaching virtual person’ block) were
entered as dependent variable, and treatment group (oxytocin/placebo)
was entered as between-subject factor. In order to examine effects of
oxytocin, repeated measures ANOVA’s were conducted with anxiety
and distance as dependent variables, treatment group (oxytocin/pla-
cebo) as between subject factor, and emotion (anger, fear, sadness,
happiness, disgust, neutral) as within-subject factor. Analyses were
performed separately for the ‘approaching participant’ and ‘ap-
proaching virtual person’ block. Distance in the ‘approaching partici-
pant’ and ‘approaching virtual person’ block were significantly corre-
lated (neutral condition: r= .40, p < .001), but were analysed
separately because passive approach may be more threatening to par-
ticipants than active approach. Maternal love withdrawal (continuous),
hormonal contraceptives, and menstrual phase were included as cov-
ariates in all analyses. STAI state anxiety at baseline was entered as an
additional covariate in the analyses with anxiety as dependent variable.
Country or origin was initially included as a covariate, but did not
significantly affect anxiety or distance and was therefore excluded from
the analyses. Excluding country of origin did not change the results.
3. Results
3.1. Emotional expressions
Table S3 shows that participants rated the emotions that corre-
sponded to the emotional facial expression of the avatar highest, in-
dicating that the emotions of the virtual person were correctly re-
cognized. Oxytocin did not significantly affect the ratings of the facial
expressions (ps> .19). Correlational analyses showed that maternal
love withdrawal was significantly and negatively related to the angry
ratings of the angry virtual persons, indicating that individuals with
more love withdrawal rated the angry person as less angry (see
Table 1).
3.1.1. Distance: passive approach
The repeated measures ANOVA showed that oxytocin significantly
reduced interpersonal distance when the participant was approached by
the virtual person (F(1,174)= 7.71, p= .006, partial ɳ2 = .04). In
addition, there was a significant effect of emotional expression of the
virtual person (F(3.50, 609.13)= 6.03, p < .001, partial ɳ2 = .03).
Fig. 2 and Table 2 present the mean distances across the different
Table 1
Correlations between love withdrawal and the emotion ratings that corre-
sponded to the emotional expression of the virtual person. * p< .05.
Anger Happy Afraid Disgust Sad Baseline anxiety
Love withdrawal −.18* −.07 .12 .11 .01 0.01
Fig. 2. Mean distance (virtual meters) for individuals in the placebo and oxy-
tocin group across the different emotion conditions in the participant ap-
proaches block and the virtual person approaches block. *p < .05, † p< .1.
Table 2











M SD M SD M SD M SD
Placebo
Neutral 1.05 0.46 1.34 0.66 1.82 0.50 1.82 0.49
Angry 1.66 0.73 1.82 0.67 2.31 0.70 2.40 0.74
Sad 1.12 0.50 1.38 0.67 2.03 0.63 2.06 0.58
Disgust 1.35 0.67 1.82 0.76 2.16 0.66 2.22 0.68
Happy 1.10 0.51 1.25 0.58 1.71 0.46 1.59 0.44
Afraid 1.21 0.55 1.66 0.71 1.95 0.57 2.16 0.69
Oxytocin
Neutral 0.97 0.46 1.26 0.83 1.84 0.53 1.75 0.51
Angry 1.49 0.73 1.70 0.88 2.32 0.74 2.33 0.75
Sad 0.99 0.45 1.20 0.73 2.00 0.54 2.00 0.53
Disgust 1.16 0.58 1.57 0.82 2.10 0.62 2.15 0.65
Happy 0.88 0.39 1.24 0.83 1.68 0.43 1.62 0.44
Afraid 1.06 0.49 1.39 0.80 1.98 0.58 2.03 0.59
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emotion conditions and indicate smaller distances in the sad, happy,
and neutral condition, and larger distances in the angry condition.
However, there was no significant effect of love withdrawal on inter-
personal distance (F(1,174)= 0.01, p= .931, partial ɳ2 = .00) and no
significant interaction between treatment group and emotional ex-
pression (F(3.50, 609.13)= 1.32, p= .265, partial ɳ2 = .01). Further,
we found a significant interaction between love withdrawal and treat-
ment group (F(1,174)= 4.78, p= .030, partial ɳ2 = .03). Maternal
love withdrawal was dichotomized into low and high love withdrawal
using a median split (median=2.18) in order to explore the interac-
tion. Planned contrasts with mean interpersonal distance across the
emotion conditions showed that oxytocin reduced interpersonal dis-
tance, but only for participants with lower levels of love withdrawal
(placebo: N=50, M=1.33, SD=0.53, oxytocin: N=38, M=0.99,
SD=0.45; t(176)= 3.23, p= .001) and not for individuals with
higher levels of love withdrawal (placebo: N=40, M=1.15,
SD=0.47, oxytocin: N=52, M=1.16, SD=0.45; t(176) = -0.16,
p= .873; see Fig. 3). There was no significant three-way interaction
between treatment, emotional expression, and love withdrawal (F(3.50,
609.13)= 1.44, p= .224, partial ɳ2 = .01).
3.1.2. Distance: active approach
Oxytocin also reduced interpersonal distance when the participant
actively approached the virtual person (F(1,174)= 4.72, p= .031,
partial ɳ2 = .03) and, again, the emotional expression of the virtual
person had a significant effect (F(4.36, 758.60)= 2.37, p= .046,
partial ɳ2 = .01). There was no significant effect of love withdrawal (F
(1,174)= 0.26, p= .610, partial ɳ2 = .00). Neither were there sig-
nificant interactions between treatment and love withdrawal (F
(1,174)= 2.55 p= .112, partial ɳ2 = .01), emotional expression and
treatment (F(4.36, 758.60)= 1.34, p= .250, partial ɳ2 = .01) or a
significant three-way interaction between treatment, emotional ex-
pression, and love withdrawal (F(4.36, 758.60)= 1.14, p= .338, par-
tial ɳ2 = .01).
3.1.3. Anxiety: passive approach
The repeated measures ANOVA with anxiety as dependent variable
showed that oxytocin did not significantly affect anxiety when the
participant was approached by the virtual person (F(1,173)= 1.03,
p= .416, partial ɳ2 = .00). The main effect of love withdrawal on
anxiety was not significant (F(1,173)= 0.40, p= .530, partial ɳ2 =
.00), but there was a significant effect of emotional expression on an-
xiety (F(4.17, 720.82)= 3.48, p= .004, partial ɳ2 = .02), with highest
anxiety in the anger condition and lowest anxiety in the happy and
neutral condition (see Table 2). In addition, there was a marginally
significant interaction between love withdrawal and emotional ex-
pression (F(4.17, 720.82)= 2.01, p= .088, partial ɳ2 = .01). In-
dividuals with higher levels of love withdrawal reported higher levels
of anxiety while interacting with the virtual person displaying disgust
(F(1,173)= 3.98, p= .048, partial ɳ2 = .02) and fear (F
(1,173)= 10.81, p= .001, partial ɳ2 = .06), compared to individuals
with lower levels of love withdrawal. In addition, there was a sig-
nificant interaction between treatment group and emotional expression
(F(4.17, 720.82)= 2.82, p= .023, partial ɳ2 = .02) and a significant
three-way interaction between treatment group, emotional expression,
and love withdrawal (F(4.17, 720.82)= 2.88, p= .020, partial ɳ2 =
.02). Fig. 4 presents the mean anxiety ratings across the emotion con-
ditions for individuals in the oxytocin and placebo group with lower
and higher levels of love withdrawal. Oxytocin particularly reduced
anxiety levels in the disgust condition, but only for individuals with
lower levels of love withdrawal. To summarize these findings, in-
dividuals with higher levels of love withdrawal tended to experience
more anxiety during negatively-valenced interactions (disgust and fear,
although effect size was small), but benefitted less from anxiety-redu-
cing effects of oxytocin.
3.1.4. Anxiety: active approach
The repeated measures ANOVA with anxiety in the condition in
which the participant actively approached the virtual person also
showed a significant effect of emotional expression (F(3.13,
542.09)= 9.76, p < .001, partial ɳ2 = .05), but no significant effect of
treatment (F(1,173)= 2.08, p= .151, partial ɳ2 = .01), love with-
drawal (F(1,173)= 0.02, p= .900, partial ɳ2 = .00), no significant
interactions between treatment and emotional expression (F(3.13,
542.09)= 1.07, p= .364, partial ɳ2 = .01), treatment and love with-
drawal (F(1,173)= 0.93, p= .337, partial ɳ2 = .01), or between
treatment, emotional expression, love withdrawal (F
(3.13,542.09)= 0.99, p= .400, partial ɳ2 = .01).
Fig. 3. Mean distance (virtual meters averaged across the different emotion
conditions) in the placebo and oxytocin group for individuals with low and high
love withdrawal. * p< .05.
Fig. 4. Mean state anxiety (range 1–5) during the different emotion conditions
for individuals with lower of higher levels of love withdrawal in the oxytocin or
placebo group. * p< .05.
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4. Discussion
The aim of the current study was to examine intranasal oxytocin
effects on interpersonal distance using the VR paradigm by
Steenbakkers et al. (2019), in which participants were instructed to
either approach a virtual person or to stop an approaching virtual
person at their preferred distance. Our study extends previous research
examining oxytocin effects on social approach behaviors by testing
oxytocin effects on social interactions in an optimally controlled, dy-
namically changing virtual real life setting and by inducing different
emotional facial expressions. We found that oxytocin reduced inter-
personal distance during active and passive approach. In addition,
oxytocin reduced anxiety, particularly while being approached by a
person displaying disgust, possibly because this emotion elicited feel-
ings of rejection.
However, oxytocin effects on distance were only present in women
with low maternal disciplinary use of love withdrawal indicating a
more positive family background. Moreover, women with higher levels
of maternal disciplinary love withdrawal experienced more anxiety
during negatively-valenced interactions, but benefitted less from an-
xiety-reducing effects of oxytocin.
Together, these findings do not support the social salience hypoth-
esis. In contrast to what would be expected based on the social salience
hypothesis, oxytocin did not lead to opposing effects during positively
and negatively-valenced interactions. Instead, it reduced interpersonal
distance in social contexts signalling threat (disgust, anger, fear) as well
as safety (happy, sadness). Moreover, oxytocin did not influence the
emotion ratings of the facial expressions of the virtual person, in-
dicating that it did not affect the salience of the emotional expressions.
Our results are more in line with the approach/withdrawal hypothesis.
Oxytocin stimulated approach behaviors in positively-valenced inter-
actions and reduced anxiety and withdrawal behaviors in negatively-
valenced interactions, although the effects were dependent on in-
dividual characteristics.
Which possible mechanisms may underlie reduced interpersonal
distance after oxytocin administration? One suggestion is that the
stress-reducing and anxiolytic effects of oxytocin account for increased
approach behaviors and reduced withdrawal behaviors (Piva and
Chang, 2018). Multiple studies have shown that oxytocin reduces cor-
tisol levels and stress, for example during and after psychosocial stress
(Heinrichs et al., 2003). These stress reductions may in turn facilitate
social approach behaviors during positive social interactions and re-
duce withdrawal behaviors under potentially threatening conditions. In
line with this explanation, we found that oxytocin reduced anxiety
during the interpersonal distance paradigm. Interestingly, anxiety-re-
ducing effects of oxytocin were only present when participants were
approached by a person displaying disgust, but no effects were found
during interactions with the angry or anxious virtual person. Disgust
can be interpreted as a strong social threat signalling rejection and has
been shown to be more threatening to socially anxious individuals than
angry faces (Amir et al., 2010). More pronounced anxiety-reducing
effects of oxytocin during interactions with a disgusted person may
therefore indicate that oxytocin particularly reduces social anxiety or
fear of rejection. Another mechanism underlying increased approach
behavior after oxytocin administration is that oxytocin may enhance
the rewarding value of social interactions (Piva and Chang, 2018), in
particular during positive social interactions. This hypothesis could not
be tested in the current study, as we only measured state anxiety during
the interpersonal distance paradigm.
Interestingly, anxiety-reducing effects of oxytocin during interac-
tions signalling potential social threat were more pronounced for in-
dividuals with lower levels of love withdrawal than for individuals with
higher levels of love withdrawal. Oxytocin also reduced interpersonal
distance only for individuals with lower levels of love withdrawal, but
not for individuals with higher levels of love withdrawal. This is con-
sistent with previous studies showing less pronounced oxytocin effects
in individuals with negative childhood experiences (Meinlschmidt and
Heim, 2007; Riem, Bakermans-Kranenburg, et al., 2013; Riem et al.,
2013a,b). It has been suggested that epigenetic changes after childhood
adversity result in reductions in oxytocin receptor expression and, as a
result, influence sensitivity to intranasal oxytocin (Bakermans-
Kranenburg and Van Ijzendoorn, 2017). Another explanation for a re-
duced response to intranasal oxytocin after adverse childhood experi-
ences is that adversity results in neuronal loss in stress-sensitive brain
regions that contain high densities of oxytocin receptors (Riem et al.,
2019), such as the hippocampus (Quintana et al., 2017). These neuro-
biological dysregulations after childhood adversity may in turn impede
the feedforward mechanism of the oxytocinergic system (Churchland
and Winkielman, 2012; Van IJzendoorn et al., 2012), with increased
oxytocin levels after administration propagating production and release
of endogenous oxytocin. This disrupted feedforward mechanism may
result in more short-lived oxytocin effects or even the absence of an
effect in individuals with a history of adversity. Future studies should
test whether a disrupted feedforward mechanism may indeed underlie
altered sensitivity to oxytocin administration in these individuals.
Another explanation for the less pronounced oxytocin effects in
individuals with a history of love withdrawal is that these individuals
perceived the emotional expressions of the virtual person differently.
Intranasal oxytocin might not enhance prosocial behavior in individuals
with more love withdrawal because these experiences may have re-
sulted in an insecure internal working model (Bowlby, 1969), which
may alter the interpretation of social stimuli (Zik and Robert, 2015).
Indeed, our results showed that individuals with experiences of love
withdrawal rated the angry virtual person as less angry, possibly be-
cause of attentional disengagement. A previous study showed that love
withdrawal is associated with enhanced early attention to and proces-
sing of facial stimuli as indicators of the relational consequences linked
to failure and success, but diminished attentional engagement at a later
processing stage (Huffmeijer et al., 2013). This pattern of early vigi-
lance and later avoidance has been suggested to explain attentional
biases to threat and disturbed emotional face processing in maltreated
individuals (Hein and Monk, 2017; Masten et al., 2008). One possibility
is that attentional disengagement may have resulted in reduced atten-
tion to social threat cues and may thus have interfered with anxiety-
reducing effects of oxytocin in individuals with higher levels of love
withdrawal. However, this explanation may be less likely as self-re-
ported anxiety levels were particularly high when these individuals
were approached by a person displaying negative emotions. Thus, even
though individuals with love withdrawal seemed to perceive the angry
virtual person as less threatening, they tended to experience more an-
xiety while being approached by a virtual person than individuals with
a positive family background and benefitted less from oxytocin.
It should be noted that, although the majority of previous studies
indicates that intranasal oxytocin effects are hindered in individuals
with a history of negative caregiving experiences, two studies show an
opposite pattern, with more prosocial effects of oxytocin after child-
hood adversity. Riem et al. (2014) showed that intranasal oxytocin
enhances emotion recognition, as measured with the Reading the Mind
in the Eyes Test (RMET, Baron-Cohen et al., 1997), particularly in in-
dividuals who reported higher levels of maternal use love withdrawal.
Similarly, Schwaiger et al. (2019) showed improved performance on
the RMET after oxytocin administration in individuals with a history of
adversity, but not in individuals without adverse experiences. Oxytocin
may particularly improve emotion recognition in individuals with ad-
versity, because negative parenting experiences increase the risk for
developing poor theory of mind skills (Cicchetti et al., 2003). Indeed,
research shows that oxytocin effects are a function of the baseline socio-
emotional abilities, with stronger effects for individuals who fail to
interpret social cues at baseline (Luminet et al., 2011). Together, this
pattern of findings seems to indicate that the moderating influence of
caregiving experiences on the effects of oxytocin may depend on the
outcome that is at stake. Whereas anxiolytic effects and effects on social
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behavior seem to be hindered in individuals with a history of adversity,
improvements in socio-cognitive functioning after intranasal oxytocin
may be preserved.
An interesting finding of the current study is that oxytocin affected
state anxiety during the interpersonal distance paradigm, but the di-
rection of the effects was dependent on experiences of love withdrawal
and the emotional expression of the virtual person. This indicates that
the effect of oxytocin was shaped by an individual difference and social
context factor and adds to many previous studies pointing to a variety
of social contexts and individual difference moderators of the effects of
oxytocin (Bartz et al., 2011; Shamay-Tsoory and Abu-Akel, 2016).
Moreover, our study extends previous studies by simultaneously ex-
amining both contextual and individual difference moderators, which is
important because these moderators are likely interrelated. More spe-
cifically, the way one perceives a certain stimulus or social context
(e.g., what constitutes a cue of social threat) may depend on the per-
sonal relevance of that social stimulus. Indeed, Harari-Dahan and
Bernstein (2017) recently showed that oxytocin effects are modulated
by the degree to which social or non-social stimuli have motivational
relevance. They found that, rather than enhancing the salience of social
stimuli per se, oxytocin stimulates approach behaviors only when the
stimuli are emotionally evocative and motivationally relevant for the
participant. Future studies should therefore simultaneously examine
both individual difference and context factors.
Examining both individual difference and contextual factors will
offer a better integrated framework for the role of oxytocin in social
behavior and decision making, which is needed to advance under-
standing of oxytocin’s therapeutic potential for clinical groups. Our
finding that oxytocin reduced anxiety during personal space intrusion is
consistent with prior studies showing anxiolytic oxytocin effects during
social stress (e.g. Heinrichs et al., 2003) and may have clinical im-
plications. For example, there is increasing interest for potential ther-
apeutic use of oxytocin for the treatment of psychopathologies asso-
ciated with anxiety and social dysfunctions, such as generalized anxiety
disorder or posttraumatic stress disorder (Neumann and Slattery,
2016). However, clinical trials examining oxytocin effects in psychiatric
groups have shown disappointing results so far, with mixed effects
(Guastella et al., 2015, 2009). Meta-analyses examining beneficial
oxytocin effects in clinical groups show that effects are inconclusive (De
Cagna et al., 2019; Keech et al., 2018) or are limited to psychiatric
conditions with etiological factors unrelated to childhood adversity
(e.g. autism; Bakermans-Kranenburg and Van IJzendoorn, 2013). Thus,
there is no strong evidence that oxytocin may be an effective pharma-
cological intervention for reducing general psychiatric symptoms.
However, the majority of clinical trials so far have neglected the role of
individual differences in sensitivity to intranasal oxytocin and the role
of social context. Given the evidence for a dysregulated oxytocin system
after childhood adversity, future clinical studies should therefore take
into account the role of childhood trauma and examine whether oxy-
tocin may be effective for specific diagnostic subgroups without
trauma. Moreover, future studies should examine how negative child-
hood experiences result in a dysregulated oxytocin system and in-
vestigate whether individuals with trauma do benefit from repeated
intranasal oxytocin or different dosages and/or in different stages of the
therapeutic process.
Some limitations should be noted. First, although the ratings of the
emotional expressions of the virtual person showed that the emotions
were all correctly recognized, the emotional expressions may have
differed in the clarity by which the emotion was expressed. For ex-
ample, the angry facial expressions and gestures of the virtual person
may be easier to recognize than the expressions and gestures of the
happy virtual person. Second, we cannot rule out influences of pre-
existing differences between the oxytocin and placebo group because of
the use of a between-subject design, although randomization has re-
duced this risk. Another limitation is the use of a short retrospective
self-report questionnaire to assess childhood experiences. In addition,
only the relationship with mother was assessed. Interviews assessing
the quality of relationship of both parents might yield more valid data.
Lastly, the findings of the current study can only be generalized to
women without children.
5. Conclusions
Using the innovative, immersive VR paradigm by Steenbakkers et al.
(2019) we examined oxytocin effects on interpersonal distance in a
dynamically changing, but optimally controlled real life setting. This
study is the first to investigate how contextual and individual char-
acteristics in tandem modulate the effects of oxytocin on prosocial be-
havior in VR. We found that oxytocin reduced interpersonal distance
between a participant and a virtual person with various emotional ex-
pressions. Oxytocin effects on approach behavior were particularly
pronounced in individuals with lower levels of (disciplinary) maternal
love withdrawal, but absent in individuals with higher levels of love
withdrawal. Moreover, women with higher levels of maternal dis-
ciplinary love withdrawal experienced more anxiety while being ap-
proached by a virtual person than individuals with a more positive
family background regarding this aspect, but benefitted less from oxy-
tocin. This is consistent with previous research showing a dysregulated
oxytocinergic system after childhood adversity and may indicate that
oxytocin may be less effective for individuals who are most in need of
an intervention because of a problematic family background.
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